Skip to main content
logo
Cynata Therapeutics Limited (CYYNF)
OTCMKTS · Delayed Price · Currency is USD
0.2200
0.00 (0.00%)
At close: Feb 2, 2026

Cynata Therapeutics Revenue

In the fiscal year ending June 30, 2025, Cynata Therapeutics had annual revenue of 1.89M AUD, down -18.59%. Cynata Therapeutics had revenue of -84.99K in the half year ending June 30, 2025.

Revenue
1.89M AUD
Revenue Growth
-18.59%
P/S Ratio
54.81
Revenue / Employee
942.57K AUD
Employees
2
Market Cap
67.74M USD

Revenue Chart

* This company reports financials in AUD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 20251.89M-430.50K-18.59%
Jun 30, 20242.32M661.33K39.98%
Jun 30, 20231.65M-6.12M-78.71%
Jun 30, 20227.77M6.22M402.60%
Jun 30, 20211.55M-5.47M-77.95%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
BioStem Technologies292.21M
Vaxart148.20M
Nuo Therapeutics2.61M
Harvard Apparatus Regenerative Technology743.00K
ZIVO Bioscience209.03K
Arch Biopartners198.11K
Revenue Rankings

Cynata Therapeutics News

More News